Abbott Laboratories Stock Checkup for May
With shares up by a double-digit percentage so far in 2013, how does Abbott Laboratories stock look now? Find out in this month's stock checkup.
Any Light at the End of the Tunnel for Alzheimer's Disease?
Failed Alzheimer's disease programs litter the pharmaceutical landscape. Is there any hope for this horrible disease? Maybe so.
2 Scariest Dividend Stocks in Health Care
The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.
2 Red Flags for Merck's Type 2 Diabetes Blockbuster
A Fool breaks down the unexpected slide in Januvia/Janumet revenue in the first quarter.